ProShares - UltraShort Health Care (RXD) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

ProShares - UltraShort Health Care (RXD) Financial Services Profile

ProShares UltraShort Health Care (RXD) is a geared ETF providing -2x daily exposure to the S&P Health Care Select Sector Index, appealing to sophisticated investors seeking short-term, inverse exposure to the health care sector. It offers a tactical tool for hedging or potentially profiting from anticipated downturns in the health care market.

What Is the Investment Thesis for RXD?

ProShares UltraShort Health Care (RXD) presents a tactical opportunity for investors with a bearish outlook on the health care sector. The fund's -2x leverage offers the potential for amplified gains when the S&P Health Care Select Sector Index declines. However, this leverage also magnifies losses if the index rises. Key considerations include the fund's daily reset feature, which can lead to performance erosion over longer holding periods, particularly in volatile markets. Investors should closely monitor health care sector trends, regulatory changes, and economic factors that could impact the index. RXD is best suited for short-term trading strategies and hedging purposes, rather than long-term investment.

Based on FMP financials and quantitative analysis

RXD Key Highlights

RXD seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the S&P Health Care Select SectorSM Index.

• The fund is designed for sophisticated investors with a high-risk tolerance and a short-term trading horizon.
• RXD offers intraday liquidity, allowing investors to buy and sell shares throughout the trading day.
• Due to the leveraged nature of the fund, its performance can deviate significantly from the underlying index over longer periods, especially in volatile markets.
• The fund's beta is -1.09, indicating an inverse correlation with the market.

Who Are RXD's Competitors?

RXD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are RXD's Key Strengths?

Leveraged inverse exposure provides the potential for high returns in a declining health care market.

• Intraday liquidity allows for flexible trading strategies.
• Established brand recognition in the ETF market.

What Are RXD's Weaknesses?

Leverage magnifies losses if the health care sector rises.

• Daily reset can lead to performance erosion over longer periods.
• High expense ratio compared to non-leveraged ETFs.

What Could Drive RXD Stock Higher?

Potential for increased volatility in the health care sector due to upcoming regulatory changes.

• Continued economic uncertainty and geopolitical risks driving demand for inverse ETFs.
• Technological disruptions in the health care industry creating opportunities for short-term trading strategies.

What Are the Key Risks for RXD?

Unexpected rallies in the health care sector leading to significant losses.

• Changes in regulations governing leveraged ETFs.
• High expense ratio compared to non-leveraged ETFs.
• Daily reset leading to performance erosion over longer periods.

What Are the Growth Opportunities for RXD?

• Increased Volatility in Healthcare Sector: Ongoing: The healthcare sector is subject to regulatory changes, drug pricing debates, and technological advancements, all of which can create volatility. RXD can capitalize on increased volatility as investors seek to hedge their portfolios or profit from short-term declines. The market size for inverse ETFs is directly correlated with market volatility, and the healthcare sector is expected to remain volatile due to political and economic factors.
• Rising Interest Rates: Ongoing: Rising interest rates can negatively impact growth stocks, including those in the healthcare sector. RXD can benefit from this trend as investors seek to hedge their exposure to healthcare companies that are sensitive to interest rate changes. The market for inverse ETFs that target interest rate-sensitive sectors is expected to grow as the Federal Reserve continues to tighten monetary policy.
• Geopolitical Risks: Ongoing: Geopolitical tensions and trade disputes can create uncertainty in global markets, leading to increased demand for safe-haven assets and inverse ETFs. RXD can benefit from this trend as investors seek to protect their portfolios from geopolitical risks. The market size for inverse ETFs that target specific sectors or countries is expected to grow as geopolitical risks remain elevated.
• Technological Disruption in Healthcare: Ongoing: Rapid technological advancements in healthcare, such as artificial intelligence and telemedicine, can disrupt traditional healthcare business models. RXD can capitalize on this disruption as investors seek to profit from the decline of companies that are slow to adapt to technological changes. The market for inverse ETFs that target disrupted industries is expected to grow as technology continues to transform the global economy.
• Increased Adoption of Short-Term Trading Strategies: Ongoing: The rise of online trading platforms and mobile apps has made it easier for investors to engage in short-term trading strategies. RXD is well-suited for short-term trading due to its leveraged inverse exposure. The market for leveraged and inverse ETFs is expected to grow as more investors adopt short-term trading strategies.

What Are RXD's Competitive Advantages?

• First-mover advantage in offering leveraged inverse exposure to the S&P Health Care Select Sector Index.
• Established brand recognition in the ETF market.
• Proprietary trading strategies and risk management expertise.

What Does RXD Do?

ProShares UltraShort Health Care (RXD) is designed for sophisticated investors seeking to achieve a multiple of the inverse of the daily performance of a specific index. Specifically, RXD aims to deliver two times the inverse (-2x) of the daily performance of the S&P Health Care Select Sector Index, before fees and expenses. This fund is not intended for long-term investment and is best suited for investors with a high-risk tolerance and a short-term trading horizon. The S&P Health Care Select Sector Index represents the health care sector of the S&P 500, including companies from industries such as pharmaceuticals, biotechnology, health care equipment, and health care services. RXD provides a way for investors to potentially profit from a decline in the value of these companies, using a leveraged inverse strategy. As an ETF, RXD offers intraday liquidity, allowing investors to buy and sell shares throughout the trading day. However, due to the leveraged nature of the fund, its performance can deviate significantly from the underlying index over longer periods, especially in volatile markets. Investors should carefully monitor their positions and understand the risks associated with leveraged and inverse ETFs.

What Products and Services Does RXD Offer?

• Provides leveraged inverse exposure to the S&P Health Care Select Sector Index.
• Offers a way to potentially profit from short-term declines in the health care sector.
• Designed for sophisticated investors with a high-risk tolerance.
• Trades like a stock on major exchanges.
• Offers intraday liquidity.
• Resets daily, which can lead to performance erosion over longer periods.

How Does RXD Make Money?

• RXD generates revenue through management fees charged to investors.
• The fund's performance is directly linked to the performance of the S&P Health Care Select Sector Index.
• The fund uses a leveraged inverse strategy to amplify its returns.

What Industry Does RXD Operate In?

The asset management industry is characterized by intense competition, with firms vying for market share based on investment performance, fees, and product innovation. ETFs like RXD offer specialized exposure to specific sectors or investment strategies, catering to investors with diverse risk appetites and investment objectives. The health care sector, in particular, is subject to regulatory scrutiny and market volatility, creating opportunities for inverse ETFs like RXD to capitalize on short-term declines. The industry faces ongoing pressure to reduce fees and improve transparency, driving innovation in product design and distribution.

Who Are RXD's Key Customers?

• Sophisticated investors
• High-risk tolerance traders
• Investors seeking short-term exposure to the health care sector
• Investors hedging their portfolios against potential declines in health care stocks

ProShares - UltraShort Health Care (RXD) Valuation Context

Relative to its peer group, RXD's quantitative score of 47/100 is below the peer average of 72/100.

Return on equity for ProShares - UltraShort Health Care stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. RXD trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

RXD Financials

RXD Latest News

No recent news available for RXD.

RXD Analyst Consensus

RXD MoonshotScore

RXD Financial Services Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources